10-Q: Q3 2024 Earnings Report

SECNov 12 17:22 ET · Announcements

8-K: Biote Reports Third Quarter 2024 Financial Results Continued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to strengthen competitive advantages

SECNov 12 16:26 ET

10-Q: Q2 2024 Earnings Report

SECAug 9 13:57 ET · Announcements

8-K: Biote Reports Second Quarter 2024 Financial Results Procedure revenue growth accelerates sequentially BioteRx roll-out on track with further expansion planned Management reiterates 2024 financial guidance

SECAug 8 16:48 ET

10-Q: Q1 2024 Earnings Report

SECMay 10 15:09 ET · Announcements

BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 8-K: Biote Reports Third Quarter 2023 Financial Results Achieves Progress in Test of Complementary Wellness Therapeutics Reiterates 2023 Financial Guidance

SECNov 7, 2023 17:10 ET